Renal effects of high dose celecoxib (C) during 2 phase II trials for hormone resistant prostate cancer (HRPC)

4751 Background It is unknown if high doses of Cox -2 inhibitors in cancer regimens have adverse renal effects. Concerns include acute renal failure (ARF), hyperkalemia (hyper K), proteinuria and h...